TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
Condition: Ulcerative Colitis (UC) Interventions: Drug: TD-1473 Dose A; Drug: TD-1473 Dose B; Drug: TD-1473 Dose C Sponsor: Theravance Biopharma Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials